You have no items in your shopping cart.
C225H347N47O69, MW 4814.51
Description
Tirzepatide GLN19 deamidation impurity is a high-purity impurity reference standard used for impurity profiling, analytical method development, and quality control of Tirzepatide. Deamidation at glutamine residue 19 is a well-characterized degradation pathway in peptide drug substances that can be monitored by HPLC and LC-MS. This reference standard supports accurate detection and quantification of deamidated species, ensuring product consistency and compliance with regulatory expectations throughout manufacturing and stability programs.
Specifications
| Parameter | Value |
| API Category | Tirzepatide Impurity |
| Appearance | Off-white lyophilized powder |
| Catalog Number | BF-Q19 |
| CAS Number | N/A |
| Molecular Formula | N/A |
| Molecular Weight | N/A |
| Solubility | 20% ACN in water |
| Storage Condition | -20±5°C, protect from light and moisture |
| Synonyms | GLN19 deamidation variant |
Applications
-
Pharmaceutical impurity profiling and quality control
-
HPLC and LC-MS/MS method development and validation
-
Drug substance and drug product release testing
-
Stability studies and forced degradation analysis
-
Regulatory submission support (FDA, EMA, ICH guidelines)
Documents
MSDS
COA
When can I expect my order to ship?
Most orders are filled and shipped within 2-3 business days from the time they are received.
Our standard shipping usually take 2-5 days.
We also provide express shippping for time-sensitive deliveries.
Email contact@biofargo.com if you have any requirements.

